Regionhospital Hammel Neurocenter, Research Unit
Hammel, 8450, Denmark
NCT Number: NCT01983319
The aim of this study is to determine whether noninvasive brain stimulation in form of active transcranial direct current stimulation (tDCS) combined with constraint induced movement therapy (CIMT) offers an additional benefit as compared with sham tDCS combined with CIMT in patients with stroke. Furthermore the purpose is to highlight changes in GABA activity more than 3 months after stroke and its importance for effect of tDCS and CIMT combined with tDCS.
Looking for future studies?
Notify Me18 year–80 year
All sexes
Interventional
Not applicable
Hammel, 8450, Denmark
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Anodal transcranial Direct Current Stimulation 1.5 mA in 30 minutes with CIMT
Other names: tDCS, Non invasive brain stimulation, transcranial stimulation
sham transcranial Direct Current Stimulation 30 min with CIMT
Other names: placebo stimulation
2 weeks of CIMT
Other names: CIMT
Time frame: Baseline and posttest (an average of 2 weeks from baseline)
The motor function assessment will be done with: Wolf Motor Function Test
Time frame: Baseline
Assessment of GABA activity using MRI spectroscopy. Measurements will be compared between patients undergoing CIMT and healthy subjects.
University of Aarhus
Other
Transcranial Direct Current Stimulation Combined With Constraint Induced Movement Therapy and Role of GABA Activity in Stroke Recovery
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02425345
Arterial Occlusive Diseases, Arteriosclerosis
View Trial DetailsNCT05589402
Bone Diseases, Brain Diseases
Harlingen, Texas, United States
View Trial DetailsNCT06750692
Brain Diseases, Cardiovascular Diseases
Afyonkarahisar, Turkey (Türkiye)
View Trial DetailsNCT04992195
Alzheimer Disease, Arterial Thromboembolism
Hong Kong
View Trial Details